Improved Clinical Outcome for Children with T-Lineage Acute Lymphoblastic Leukemia After Contemporary Chemotherapy: A Children's Cancer Group Study

References

• Greaves M. F. Differentiation-linked leukemogenesis in lymphocytes. Science 1986; 234: 697
   PubMed Web of Science ®Google Scholar
• Champlin R., Gale R. P. Acute lymphoblastic leukemia: Recent advances in biology and therapy. Blood 1989; 73: 2051
   PubMed Web of Science ®Google Scholar
• Smith M., Arthur D., Camitta B., Carroll A. J., Crist W., Gaynon P., Gelber R., Heerema N., Korn E., Link M., Murphy S., Pui C.-H., Pullen J., Reaman G., Sallon S. E., Sather H., Shuster J., Simon R., Trigg M., Uckun F., Ungerleider R. A uniform approach to risk-classification and treatment assignment for children with acute lymphoblastic leukemia (ALL). J. Clin. Oncol. 1996; 14: 18
   PubMed Web of Science ®Google Scholar
• Pui C. H. Childhood leukemias. N. Eng. J. Med. 1995; 332: 1618
   PubMed Web of Science ®Google Scholar
• Larson R. A., Dodge R. K., Burns C. P., Lee E. J., Stone R. M., Schulman P., Duggan D., Davey F. R., Sobol R. E., Frankel S. R., Hooberman A. L., Westbrook C. A., Arthur D. C., George S. L., Bloomfield C. D., Schiffer C. A. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and leukemia group B study 8881. Blood 1995; 85: 2025
   PubMed Web of Science ®Google Scholar
• Hoelzer D., Tiel E., Loffler, Buchner T., Ganser A., Heil G., Koch P., Freund M., Diedrich H., Ruhl H., Maschmeyer G., Lipp T., Nowrousian M. R., Burkert M., Gerecke D., Pralle H., Muller U., Lunscken Ch, Fulle H., Ho A. D., Kuchler R., Busch F. W., Schneider W., Gorg Ch, Emmerich B., Braumann D., Vaupel H. A., Von Paleske A., Bartles H., Neiss A., Messerer D. Prognostic factors in a multi-center study for treatment of acute lymphoblastic leukemia in adults. Blood 1988; 17: 123
   Google Scholar
• Reiter A., Schrappe M., Ludwig W. D., Hiddemann W., Sauter S., Henze G., Zimmermann M., Lampert F., Havers W., Niethammer D., Odenwald E., Riter J., Mann G., Welte K., Gadner H., Riehm H. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 1994; 84: 3122
   PubMed Web of Science ®Google Scholar
• Trigg M. E., Gaynon P., Uckun F. M. Acute lymphoblastic leukemia in children. Cancer Medicine, 4th Edition, F. James, Emile Fry Holland, III, C. Robert, W. Bast, Jr., Donald, L. Kufe Donald, Ralph R. Morton, Weichselbaum, 1996, in press
   Google Scholar
• Shorin M. A., Blattner S., Gelber R. D., Tarbell N. J., Donnelly M., Dalton V., Cohen H. J., Sallan S. E. Treatment of childhood acute lymphoblastic leukemia: Results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium protocol 85–01. J. Clin. Oncol. 1994; 12: 740
   PubMed Web of Science ®Google Scholar
• Foon K. A., Tood R. F., III. Immunologic classification of leukemia and lymphoma. Blood 1986; 68: 1
   PubMed Web of Science ®Google Scholar
• Pui C. H., Behm F. G., Crist W. M. Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood 1993; 82: 343
   PubMed Web of Science ®Google Scholar
• Reinherz E. L., Kung P. C., Goldstein G., Levey R. H., Schlossman S. F. Discrete stages of human intrathymic differentiation: Analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc. Natl. Acad. Sci. USA 1980; 77: 1588
   PubMed Web of Science ®Google Scholar
• Crist W., Shuster J., Look T., Borowitz M., Behm F., Bowman P., Frankel L., Pullen J., Krance R., Steuber P., Camitta B., Amylon M., Link M., Land V. Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. Leukemia 1992; 6: 162
   PubMed Web of Science ®Google Scholar
• Shuster J. J., Falletta J. M., Pullen D. J., Crist W. M., Humphrey G. B., Dowell B. L., Wharam M. D., Borowitz M. Prognostic factors in childhood T-cell acute lymphoblastic leukemia: A Pediatric Oncology Group Study. Blood 1990; 75: 166
   PubMed Web of Science ®Google Scholar
• Pui C. H., Behm F. G., Singh B., Schell M. J., Williams D. L., Rivera G. K., Kalwinsky D. K., Sandlund J. T., Crist W. M., Raimondi S. C. Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia. Blood 1990; 75: 174
   PubMed Web of Science ®Google Scholar
• Pullen D. J., Sullivan M. P., Faletta J. M., Boyett J. M., Humphrey G. B., Starling K. A., Land V. J., Dyment P. G., Vats T., Duncan M. H. Modified LSA2-L2 treatment in 53 children with E-rosette-positive T-cell leukemia: Results and prognostic factors: A Pediatric Oncology Group Study. Blood 1982; 60: 1159
   PubMed Web of Science ®Google Scholar
• Borowitz M. J., Dowell M. L., Boyett J. M., Pullen J., Crist W. M., Quddus F. M., Falletta J. M., Metzgar R. S. Clinicopathologic aspects of E rosette negative T-cell acute lymphocytic leukemia: A Pediatric Oncology Group study. J. Clin. Oncol. 1986; 4: 170
   PubMed Web of Science ®Google Scholar
• Gaynon P., Steinherz P., Bleyer W. A., Ablin A., Albo V., Finkelstein J., Grossman N., Littman P., Novak L., Pyesmany A., Reaman G., Sather H., Hammond D. Intensive therapy for children with acute lymphoblastic leukemia and unfavorable presenting features. Lancet 1988; ii: 921
   Google Scholar
• Steinherz P., Gaynon P., Miller D., Reaman G., Bleyer W. A., Finkelstein J., Evans R., Meyers P., Steinherz L., Sather H., Hammond D. Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York Regimen—A new intensive therapy protocol. J. Clin. Oncol. 1986; 4: 744
   PubMed Web of Science ®Google Scholar
• Tubergen D., Gilchrist G., O'Brien R., Coccia P., Sather H., Waskerwitz M., Hammond D. Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features. J. Clin. Oncol. 1993; 11: 527
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Myers D. E., Jaszcz W., Haissig S., Gajl-Peczalska K., Ledbetter J. A. Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells. Blood 1990; 76: 2449
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Gajl-Peczalska K. J., Provisor A. J., Heerema N. A. Jmmunophenotype-karyotype associations in human acute lymphoblastic leukemia. Blood 1989; 73: 271
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Ledbetter J. A. Immunobiologic differences between normal and leukemic human B-cell precursors. Proc. Natl. Acad. Sci. USA 1988; 85: 8603
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Gajl-Peczalska K. J., Ledbetter J. A., Koller B. Biphenotypic leukemic lymphocyte precursor in CD2+ CD 19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues. Blood 1989; 73: 1000
   PubMed Web of Science ®Google Scholar
• Gaynon P., Steinherz P., Bleyer W. A., Albin A., Albo V., Finkelstein J., Grossman N., Novak L., Pyesmany A., Reaman G., Chappell R., Sather H., Hammond D. Improved therapy for children with acute lymphoblastic leukemia and unfavorable features: A follow-up report of the Childrens Cancer Group Study CCG-106. J. Clin. Oncol. 1993; 11: 2234
   PubMed Web of Science ®Google Scholar
• Gaynon P. A., Bostrom B., Reaman G., Sather H., Trigg M. E., Tebergen D. G., Uckun F. M. Childrens Cancer Group (CCG) initiatives in childhood acute lymphoblastic leukemia (ALL). Am. J. Pediatri. Hematol./Oncol. 1996, in press
   Google Scholar
• Gaynon P., Bleyer W. A., Stienherz P., Finkelstein J., Littman P., Miller D., Reaman G., Sather H., Hammond D. Modified BFM therapy for children with previously untreated acute lymphoblastic leukemia and unfavorable features. Am. J. Pediatri. Hematol./Oncol. 1988; 10: 42
   PubMedGoogle Scholar
• Trigg M., Gaynon P., Reaman G., Steinherz P., Sather H., Cairo M., Hammond D. Treatment strategy for children with acute lymphoblastic leukemia and unfavorable features: CCG studies. Cancer Chemotherapy: Challenges. for the Future. Excerpta Medica, Ltd., Tokyo 1993; Vol. 8: 260–267
   Google Scholar
• Tubergen D., Gilchrist G., O'Brien R., Coccia P., Sather H., Waskerwitz M., Hammond D. Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: Comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy. J. Clin. Oncol. 1993; 11: 520
   PubMed Web of Science ®Google Scholar
• Cherlow J., Steinher P., Sather H., Gaynon P., Grossman N., Kersey J., Maurer H., Brenneman J., Trigg M., Hammond D. The role of radiation therapy in the treatment of acute lymphocytic leukemia with lymphomatous presentation. Int. J. Radiat. Oncol., Biol, Phys. 1993; 27: 1001
   PubMed Web of Science ®Google Scholar
• Reaman G., Feusnew J., Heerema N., Steinherz P. G., Zeltzer P., Bleyer W. A., Sather H., Hammond G. D. Intensive systemic intrathecal chemotherapy improves the outcome for infants with acute lymphoblastic leukemia. Proc. Am. Soc. Clin. Oncol. 1989; 34, Abstract)
   Google Scholar
• Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958; 53: 457
   Web of Science ®Google Scholar
• Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep. 1966; 50: 163
   PubMedGoogle Scholar
• Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient, II. Analysis and examples. Br. J. Cancer 1977; 35: 1
   PubMed Web of Science ®Google Scholar
• Breslow N. Analysis of survival data under the proportional hazards model. Int. Stat. Rev. 1975; 43: 45
   Web of Science ®Google Scholar
• Cox D. R. Regression models and life tables. J. R. Stat. Soc. B. 1972; 34: 187–220
   Google Scholar
• Thomas D., Breslow N., Gart J. Trend and homogeneity analyses of proportions and life table data. Comput. Biomed. Res. 1977; 10: 373
   PubMedGoogle Scholar
• Sen L. S., Borella L. Clinical importance of lymphoblasts with T-markers in childhood acute leukemia. N. Engl. J. Med. 1975; 292: 828
   PubMed Web of Science ®Google Scholar
• Greaves M. F., Janossy G., Peto J., Kay H. Immunologically defined subclasses of acute lymphoblastic leukemia in children: Their relationship to presentation and prognosis. Br. J. Haematol. 1981; 48: 179
   PubMed Web of Science ®Google Scholar
• Greaves M. F. Biological basis of differential prognosis in immunologically defined subclases of acute lymphoblastic leukemia. Leukemia Markers, W. Knapp. Academic Press, New York/London 1981; 463
   Google Scholar
• Niemeyer C. M., Hitchcock-Bryan S., Sallan S. E. Comparative analysis of treatment programs for childhood acute lymphoblastic leukemia. Semin. Oncol. 1985; 12: 122
   PubMed Web of Science ®Google Scholar
• Goldie J. H., Coldman A. J. The genetic origin of drug resistanc ein neoplasms: Implications for system therapy. Cancer Reserach 1984; 44: 3643
   PubMed Web of Science ®Google Scholar
• Norton L., Simon R. Tumor size and sensitivity to therapy and design of treatment schedules. Cancer Treatment Report 1977; 61: 1307
   PubMedGoogle Scholar
• Rivera G. K., Raimondi S. C., Hancock M. L, Behm F. G., Pui Ch., Abramowitch M., Mirro J., Jr., Ocks Js., Look A. T., Williams D. L., Murphy S. B., Dhl G. V., Kalwinsky D. K., Evans W. E., Kun L. E., Simone J. V., Crist W. M. Improved outcome in childhood acute lymphoblastic leukemia with reinforced early treatment and rotational combination chemotherapy. Lancet 1991; 337: 61
   PubMed Web of Science ®Google Scholar
• Chessells J. M., Bailey C., Richards S. M. Intensification of treatment and survival in all children with lymphoblastic leukemia: Results of the UK Medical Research Council trial UKALL X. Lancet 1995; 345: 143
   PubMed Web of Science ®Google Scholar
• Rabbitts T. H. Chromosomal translocations in human cancer. Nature 1994; 372: 143
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Reaman G. H. Immunotoxins for treatment of leukemia and lymphoma. Leukemia and Lymphoma 1995; 18: 195
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Evans W. E., Forsyth C. J., Waddick K. G., Tahlgren L., Chelstrom L. M., Burkhardt A., Bolen J., Myers D. E. Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Science 1995; 267: 886
   PubMed Web of Science ®Google Scholar